A
DNA icon

AlphaQuest’s Ginkgo Bioworks DNA Stock Holding History

AlphaQuest’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,279
Closed -$310K – 580
2025
Q4 		$310K Buy
37,279
+26,617
+250% +$287K 0.02% 1191
2025
Q3 		$155K Sell
10,662
-5,014
-32% -$60K 0.01% 1528
2025
Q2 		$176K Sell
15,676
-22,396
-59% -$174K 0.02% 1203
2025
Q1 		$217K Buy
+38,072
New +$388K 0.02% 942

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaQuest's DNA Position: Q1 2026 in Review

AlphaQuest sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 37,279 shares — an estimated $310K sold.

AlphaQuest first reported a position in DNA in Q1 2025 and held it in 4 quarters. The position peaked at $310K in Q4 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • AlphaQuest reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 37,279 Ginkgo Bioworks shares in Q1 2026, an estimated $310K.
  • AlphaQuest first reported a position in Ginkgo Bioworks in Q1 2025 and held it in 4 quarters.
  • AlphaQuest's Ginkgo Bioworks position peaked at $310K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.